Out-of-specification tisagenlecleucel does not compromise safety or efficacy in pediatric acute lymphoblastic leukemia.

Document Type

Article

Publication Date

11-25-2021

Identifier

DOI: 10.1182/blood.2021012392

Journal Title

Blood

Volume

138

Issue

21

First Page

2138

Last Page

2142

Library Record

Share

COinS